Browsing: Peptide

Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Press release Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Analysis Highlights Growth To $32.86 Billion By 2030 At 16.2% CAGR 08-19-2026 12:56 PM CET | Health & MedicinePress release from: The Business Research Company Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market The market for glucagon-like peptide…

On July 27, REX Shares filed for the REX Peptides ETF tracking the VettaFi Peptides Index. The fund targets companies strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products. Peptides, short chains of amino acids linked together in a specific sequence, appear in a range of products including medicines, dietary supplements,…

One of the hallmarks of Alzheimer’s disease is the accumulation of a peptide in the brain known as amyloid beta. A new Nature Communications study published July 22 has uncovered the atomic structure of the peptide when it’s damaging to the brain

Federal health advisers are meeting to review a group of controversial chemicals called peptides

Samsung Biologics (207940.KS) has made the largest investment in the history of Korean pharmaceutical and biotech mergers and acquisitions (M&A) to enter the peptide contract development and manufacturing organization (CDMO) business, aiming to secure a competitive edge in the global obesity treatment market, which is expected to grow to 200 trillion won over the next…

Fermentation-derived peptides are starting to turn up in protein products and early-stage bakery and snack formulations, as manufacturers test whether they can deliver a genuine functional benefit rather than simply riding the GLP-1 wave

This is a paid press release. Contact the press release distributor directly with any enquiries.